Polar Securities »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Polar Securities

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Polar Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $48M 40M 1.19
2024-06-30 $22M 20M 1.11
2024-03-31 $20M 20M 0.98
2023-12-31 $19M 20M 0.93
2023-09-30 $19M 20M 0.94

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Sprott Physical Gold Tr Unit (PHYS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Axon Enterprise Note 0.500%12/1 (Principal)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Sprott Physical Silver Tr Tr Unit (PSLV)
Fluor Corp Note 1.125% 8/1 (Principal)
Tetra Tech DBCV 2.250% 8/1 (Principal)
Post Hldgs Note 2.500% 8/1 (Principal)

View all positions for Polar Securities

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1